These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 85354)

  • 21. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.
    Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD
    Neurology; 1976 Nov; 26(11):1054-9. PubMed ID: 988512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial myasthenia gravis.
    Honeybourne D; Dyer PA; Mohr PD
    J Neurol Neurosurg Psychiatry; 1982 Sep; 45(9):854-6. PubMed ID: 7131024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiacetylcholine receptor antibody and its relationship to HLA type in asymptomatic siblings of a patient with myasthenia gravis.
    Seybold ME; Lindstrom JM
    Neurology; 1981 Jun; 31(6):778-80. PubMed ID: 7195498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
    Huang GZ; Lo YL
    J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-acetylcholine receptor antibodies.
    Vincent A; Newsom Davis J
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):590-600. PubMed ID: 7400823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gm allotypes in myasthenia gravis.
    Nakao Y; Matsumoto H; Miyazaki T; Nishitani H; Ota K; Fujita T; Tsuji K
    Lancet; 1980 Mar; 1(8170):677-80. PubMed ID: 6103092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved radioassay of anti-acetylcholine receptor antibody: application for the detection of extremely low antibody titers in sera from patients with myasthenia gravis.
    Ohta M; Ohta K; Mori F; Itoh N; Nishitani H; Hayashi K
    Clin Chem; 1990 Jun; 36(6):911-3. PubMed ID: 2357833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
    Brenner T; Abramsky O; Lisak RP; Zweiman B; Tarrab-Hazdai R; Fuchs S
    Isr J Med Sci; 1978 Sep; 14(9):986-9. PubMed ID: 721428
    [No Abstract]   [Full Text] [Related]  

  • 30. Thymectomy in late-onset myasthenia gravis.
    Olanow CW; Lane RJ; Roses AD
    Arch Neurol; 1982 Feb; 39(2):82-3. PubMed ID: 7059304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis.
    Lefvert AK; Pirskanen R; Svanborg E
    J Neuroimmunol; 1985 Jul; 9(1-2):41-53. PubMed ID: 4008636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity.
    Besinger UA; Toyka KV; Hömberg M; Heininger K; Hohlfeld R; Fateh-Moghadam A
    Neurology; 1983 Oct; 33(10):1316-21. PubMed ID: 6684226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.
    Lefvert AK; Bergström K; Matell G; Osterman PO; Pirskanen R
    J Neurol Neurosurg Psychiatry; 1978 May; 41(5):394-403. PubMed ID: 207825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myasthenia gravis: predictive factors associated with the synchronized elevation of anti-acetylcholine receptor antibody titer in Kanazawa, Japan.
    Iwasa K; Yoshikawa H; Samuraki M; Shinohara M; Hamaguchi T; Ono K; Nakamura H; Yamada M
    J Neuroimmunol; 2014 Feb; 267(1-2):97-101. PubMed ID: 24388223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylcholine receptor antibody in myasthenia gravis: purification and characterization.
    Lefvert AK; Bergström K
    Scand J Immunol; 1978; 8(6):525-33. PubMed ID: 734356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis.
    Berrih S; Morel E; Gaud C; Raimond F; Le Brigand H; Bach JF
    Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and biological evolution of myasthenia gravis after thymectomy in a 13-year-old girl].
    Denizot M; Fulpius BW; Cox JN; Ferrier PE
    Helv Paediatr Acta; 1979 Sep; 34(4):375-80. PubMed ID: 521303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological similarities between an experimental autoimmune myasthenia gravis model and human myasthenia gravis.
    Souan ML; Geffard M
    Neurosci Lett; 1986 Aug; 68(3):282-7. PubMed ID: 2427976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myasthenia gravis.
    Willcox N
    Curr Opin Immunol; 1993 Dec; 5(6):910-7. PubMed ID: 8297524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.